RE-APPOINTMENT OF MR. SANJAY SETHI (DIN: 00090277) AS MANAGING DIRECTOR OF THE COMPANY FOR A PERIOD OF FIVE YEARS
Price
▲ positive · ▼ negative · ● neutral filings · teal = economic event · numbered = multiple that day (click to pick). Times IST.
Awaiting price reaction for this filing.
Beryl Drugs Ltd has re-appointed Mr. Sanjay Sethi (DIN: 00090277) as Managing Director for a further term of 5 years, effective 11 December 2025. The re-appointment was approved by shareholders at the Annual General Meeting held on 30 September 2025. Mr. Sethi is around 62 years old, holds a B. Pharma degree, and has 43 years of experience. The filing confirms he is not debarred from holding office by any SEBI order. He is disclosed as related to a director on the board.
Continuity in leadership at the top management level, which is generally a stability signal for shareholders. No change in strategic direction or governance structure is indicated by this routine re-appointment.